The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo.
about
Systemic delivery of oncolytic viruses: hopes and hurdlesCharacterization of Antibody Bipolar Bridging Mediated by the Human Cytomegalovirus Fc Receptor gp68The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surfaceMathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital MucosaHuman cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and IIIComplement Evasion Strategies of Viruses: An Overview.Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes.An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs.Interaction and interdependent packaging of tegument protein UL11 and glycoprotein e of herpes simplex virus.Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compaEvasion of early antiviral responses by herpes simplex viruses.HSV-1 Glycoproteins Are Delivered to Virus Assembly Sites Through Dynamin-Dependent Endocytosis.Immunity to bovine herpesvirus 1: II. Adaptive immunity and vaccinology.Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity.The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa.Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease.Novel Evasion Mechanisms of the Classical Complement Pathway.Oncolytic herpes simplex virus interactions with the host immune system.Immunoglobulin superfamily members encoded by viruses and their multiple roles in immune evasion.Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases?Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.CNS Infections
P2860
Q21284969-6C5E9D11-840F-4700-A3BC-C5C8ECFD0910Q27320966-09174669-2095-4D72-B42E-38C7A9CFCBA3Q27330259-BDF59DCA-7EC7-44FD-92EF-93CAF6E37CF3Q27347896-DD9302A9-C0D1-48CF-BDDC-E9743BC88E91Q33618817-D2E2AB91-FC10-4B05-9DFE-868E1546D54FQ33804431-7D7924DE-3A4F-458D-8ED1-2EBE172C20E3Q34057952-75EF3946-0C5A-4053-88A7-50FEC5ED38A8Q34549656-391FF8F8-5D02-443A-871D-29A877AF969BQ35192694-0C6E0AFD-FE10-4BDC-837D-6CF18D083CBAQ35275146-896925B8-F9CD-4BAE-9635-C5D4547BD2A8Q35414669-28CAEAEB-28BF-4617-928A-A03A9BFC0C25Q35804208-7E5C39AB-B2C1-4B4B-8135-BFEFA14BE358Q38116993-4F9E6D50-995F-4CFA-A32F-061FC7E535D5Q38241377-20DD1001-53BB-46D5-B9A5-B8E152C1D9E0Q38257496-C7D80FE3-4CA4-4171-BB60-0CDF2315CB12Q38650844-8275EA44-530F-41B3-9D2A-905C896AF753Q38692329-9239B789-AE1C-4319-8BED-2F3FE8BA726DQ38824720-0CA4307F-768E-4074-92A7-461D1BC38161Q38920459-0213DE66-1B11-4CBD-BC3D-5C8C994483F2Q39224323-1ECEE7D2-C242-4CE1-8474-B366C15FCA39Q55397851-871ADDCB-7A8F-43B9-8B5C-138408927EAEQ55406946-75BC3456-8091-4C75-93BB-A4F3ADF521B7Q56880960-DCF6AB75-EC7F-48FA-9816-001F813DFC4F
P2860
The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The herpes simplex virus 1 IgG ...... cellular cytotoxicity in vivo.
@ast
The herpes simplex virus 1 IgG ...... cellular cytotoxicity in vivo.
@en
The herpes simplex virus 1 IgG ...... cellular cytotoxicity in vivo.
@nl
type
label
The herpes simplex virus 1 IgG ...... cellular cytotoxicity in vivo.
@ast
The herpes simplex virus 1 IgG ...... cellular cytotoxicity in vivo.
@en
The herpes simplex virus 1 IgG ...... cellular cytotoxicity in vivo.
@nl
prefLabel
The herpes simplex virus 1 IgG ...... cellular cytotoxicity in vivo.
@ast
The herpes simplex virus 1 IgG ...... cellular cytotoxicity in vivo.
@en
The herpes simplex virus 1 IgG ...... cellular cytotoxicity in vivo.
@nl
P2093
P2860
P356
P1433
P1476
The herpes simplex virus 1 IgG ...... cellular cytotoxicity in vivo.
@en
P2093
Fushan Wang
Harvey M Friedman
John M Lubinski
Sita Awasthi
P2860
P304
P356
10.1128/JVI.02509-10
P407
P577
2011-01-12T00:00:00Z